Alcon updates 2025 sales growth target to 6%-7% driven by new product launches and tariff mitigation
Seeking Alpha News (Wed, 14-May 12:05 PM ET)
Biggest stock movers Wednesday: SMCI, AMD, SONY, and more
Seeking Alpha News (Wed, 14-May 10:06 AM ET)
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga (Wed, 14-May 8:13 AM ET)
American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday
Benzinga (Wed, 14-May 7:03 AM ET)
Swiss eye care firm Alcon drops after earnings miss, flags tariff impact
Seeking Alpha News (Wed, 14-May 7:03 AM ET)
Alcon’s Resilience Amid Market Challenges: A Buy Recommendation by David Saxon
TipRanks (Wed, 14-May 6:55 AM ET)
Alcon’s Long-Term Growth Potential Outweighs Short-Term Challenges: Buy Rating Maintained
TipRanks (Wed, 14-May 6:46 AM ET)
Biggest stock movers Wednesday: SMCI, SONY, and more
Seeking Alpha News (Wed, 14-May 5:21 AM ET)
Here are the major earnings before the open tomorrow
Seeking Alpha News (Tue, 13-May 6:00 PM ET)
Alcon Non-GAAP EPS of $0.73 misses by $0.03, revenue of $2.5B misses by $20M
Seeking Alpha News (Tue, 13-May 5:04 PM ET)
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Alcon trades on the NYSE stock market under the symbol ALC.
As of May 14, 2025, ALC stock price declined to $87.24 with 5,017,871 million shares trading.
ALC has a beta of 0.93, meaning it tends to be less sensitive to market movements. ALC has a correlation of 0.42 to the broad based SPY ETF.
ALC has a market cap of $43.15 billion. This is considered a Large Cap stock.
Last quarter Alcon reported $2 billion in Revenue and $.73 earnings per share. This fell short of revenue expectation by $-69 million and missed earnings estimates by -$.04.
In the last 3 years, ALC traded as high as $101.10 and as low as $55.21.
The top ETF exchange traded funds that ALC belongs to (by Net Assets): DFIV, DFAI, NUGO, DFIC, DFAX.
ALC has underperformed the market in the last year with a price return of +8.5% while the SPY ETF gained +14.2%. However, in the short term, ALC had mixed performance relative to the market. It has outperformed in the last 3 months, returning -3.3% vs -3.4% return in SPY. But in the last 2 weeks, ALC shares have been beat by the market, returning -9.5% compared to an SPY return of +6.0%.
ALC support price is $91.61 and resistance is $94.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALC shares will trade within this expected range on the day.